I totally agree with the anon poster below. In addition, the basic biology which is a critical prerequisite for developing the relatively safe and effective drugs or treatments are still lacking in sufficient knowledge for those purposes. Investing in biotech before we gain more reliable knowledge of how our bodies work, i.e., physiology, particularly at the molecular level, simply amounts to putting a cart before the horse. Of course, we cannot wait until we know all the minute details, but, currently, we have just too little to effectively and efficiently guide us towards finding the treatments or cures that actually work. More investments in basic physiological research is what is really needed, first.